+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment



Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment



Journal of Hepatology 23(3): 283-289



In patients with primary sclerosing cholangitis cholestasis is a prominent feature of the disease. We studied the effect of cholestasis and of ursodeoxycholic acid treatment on the biliary secretion of bile acids and lipids in ten patients with primary sclerosing cholangitis. Ursodeoxycholic acid treatment for 3 months led to an increase in the biliary secretion rates of total bile acids from 0.91 mmol/h to 1.47 mmol/h, mainly due to an increase in urosodeoxycholic acid, which represented 31% of biliary bile acids. With increasing cholestasis, the biliary enrichment of the bile acid pool with urosodeoxycholic acid decreased. Biliary output of endogenous bile acids on average was unchanged, but in patients with cholestasis and diminished output before treatment, it increased after ursodeoxycholic acid. Phospholipid secretion increased from 0.26 mmol/h to 0.43 mmol/h without correlation to the degree of cholestasis. Biliary cholesterol secretion on average was unchanged after ursodeoxycholic acid (0.1 versus 0.09 mmol/h) but, in patients with cholestasis and diminished output before treatment, it increased after ursodeoxycholic acid. The decreasing enrichment of the bile acid pool with ursodeoxycholic acid with increasing cholestasis may be related to its slight effect in advanced disease. The increase in biliary phospholipid secretion may represent another mechanism of action of urosodeoxycholic acid responsible for its beneficial effect in cholestatic liver disease.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008222590

Download citation: RISBibTeXText

PMID: 8550992


Related references

Effect of ursodeoxycholic acid udca treatment on the biliary secretion of bile acids and bile lipids in primary sclerosing cholangitis psc. Gastroenterology 98(5 Part 2): A637, 1990

Ursodeoxycholic acid and biliary bile acid composition in primary sclerosing cholangitis Effect of Apo E phenotype. Gastroenterology 123(1 Suppl.): 65, 2002

Effect of ursodeoxycholic acid on biliary secretion of bile acids and lipids in PSC. Gastroenterology 106(4 Suppl. ): A989, 1994

Comparative effects of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis and primary sclerosing cholangitis. Clinical Research 37(2): 365A, 1989

Treatment of the primary biliary cirrhosis and sclerosing cholangitis with ursodeoxycholic acid. Journal of Hepatology 25(Suppl. 1): 210, 1996

Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver. Life Sciences 79(10): 1014-1019, 2006

Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid. Current Gastroenterology Reports 1(1): 38-41, 2000

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis in pregnancy. Hepatology 36(4 Part 2): 491A, 2002

Urinary excretion of ursodeoxycholic acid during treatment of patients with primary biliary cirrhosis and primary sclerosing cholangitis. Journal of Hepatology 7, 1988

The effect of ursodeoxycholic acid urso in primary sclerosing cholangitis a comparison to primary biliary cirrhosis. Gastroenterology 94(5 Part 2): A595, 1988

Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 40(3): 693-698, 2004

Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis. Digestive Diseases and Sciences 51(3): 618-622, 2006

Single dose or multiple doses of ursodeoxycholic acid are equally effective in the treatment of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 108(4 Suppl. ): A1191, 1995

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression. Hepatology 52(1): 197-203, 2010

Biliary secretion of unconjugated bile acids in patients with primary biliary cirrhosis pbc before and following ursodeoxycholic acid administration. Gastroenterology 98(5 Part 2): A578, 1990